Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

2,017 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Association of risk factors with acute myocardial infarction in Middle Eastern countries: the INTERHEART Middle East study.
Gehani AA, Al-Hinai AT, Zubaid M, Almahmeed W, Hasani MR, Yusufali AH, Hassan MO, Lewis BS, Islam S, Rangarajan S, Yusuf S; INTERHEART Investigators in Middle East. Gehani AA, et al. Among authors: yusuf s. Eur J Prev Cardiol. 2014 Apr;21(4):400-10. doi: 10.1177/2047487312465525. Epub 2012 Nov 2. Eur J Prev Cardiol. 2014. PMID: 23125402
Effects of aspirin dose when used alone or in combination with clopidogrel in patients with acute coronary syndromes: observations from the Clopidogrel in Unstable angina to prevent Recurrent Events (CURE) study.
Peters RJ, Mehta SR, Fox KA, Zhao F, Lewis BS, Kopecky SL, Diaz R, Commerford PJ, Valentin V, Yusuf S; Clopidogrel in Unstable angina to prevent Recurrent Events (CURE) Trial Investigators. Peters RJ, et al. Among authors: yusuf s. Circulation. 2003 Oct 7;108(14):1682-7. doi: 10.1161/01.CIR.0000091201.39590.CB. Epub 2003 Sep 22. Circulation. 2003. PMID: 14504182 Clinical Trial.
Association of psychosocial risk factors with risk of acute myocardial infarction in 11119 cases and 13648 controls from 52 countries (the INTERHEART study): case-control study.
Rosengren A, Hawken S, Ounpuu S, Sliwa K, Zubaid M, Almahmeed WA, Blackett KN, Sitthi-amorn C, Sato H, Yusuf S; INTERHEART investigators. Rosengren A, et al. Among authors: yusuf s. Lancet. 2004 Sep 11-17;364(9438):953-62. doi: 10.1016/S0140-6736(04)17019-0. Lancet. 2004. PMID: 15364186
Benefit of clopidogrel according to timing of percutaneous coronary intervention in patients with acute coronary syndromes: further results from the Clopidogrel in Unstable angina to prevent Recurrent Events (CURE) study.
Lewis BS, Mehta SR, Fox KA, Halon DA, Zhao F, Peters RJ, Keltai M, Budaj A, Yusuf S; CURE trial investigators. Lewis BS, et al. Among authors: yusuf s. Am Heart J. 2005 Dec;150(6):1177-84. doi: 10.1016/j.ahj.2005.01.044. Am Heart J. 2005. PMID: 16338255 Clinical Trial.
Renal function and outcomes in acute coronary syndrome: impact of clopidogrel.
Keltai M, Tonelli M, Mann JF, Sitkei E, Lewis BS, Hawken S, Mehta SR, Yusuf S; CURE Trial Investigators. Keltai M, et al. Among authors: yusuf s. Eur J Cardiovasc Prev Rehabil. 2007 Apr;14(2):312-8. doi: 10.1097/01.hjr.0000220582.19516.a6. Eur J Cardiovasc Prev Rehabil. 2007. PMID: 17446813 Clinical Trial.
2,017 results